2018-2023 Global Diabetes Injection Pens Consumption Market Report
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Diabetes Injection Pens market for 2018-2023.
Diabetes Injection Pens is used to inject insulin for the treatment of diabetes. Insulin is a hormone produced by the pancreas. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with pen needles to deliver the dose.
Over the next five years, LPI(LP Information) projects that Diabetes Injection Pens will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Injection Pens market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Insulin Pens
Pen Needles
Segmentation by application:
Hospital Pharmacy
Retail Pharmacy
Online Sales
Diabetes Clinics/ Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Novo Nordisk
Eli Lilly
AstraZeneca
Sanofi
Becton Dickinson
Owen Mumford
Delfu
Wockhardt Diabetes
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Diabetes Injection Pens consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Diabetes Injection Pens market by identifying its various subsegments.
Focuses on the key global Diabetes Injection Pens manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Diabetes Injection Pens with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Diabetes Injection Pens submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2018-2023 Global Diabetes Injection Pens Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diabetes Injection Pens Consumption 2013-2023
2.1.2 Diabetes Injection Pens Consumption CAGR by Region
2.2 Diabetes Injection Pens Segment by Type
2.2.1 Insulin Pens
2.2.2 Pen Needles
2.3 Diabetes Injection Pens Consumption by Type
2.3.1 Global Diabetes Injection Pens Consumption Market Share by Type (2013-2018)
2.3.2 Global Diabetes Injection Pens Revenue and Market Share by Type (2013-2018)
2.3.3 Global Diabetes Injection Pens Sale Price by Type (2013-2018)
2.4 Diabetes Injection Pens Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Sales
2.4.4 Diabetes Clinics/ Centers
2.5 Diabetes Injection Pens Consumption by Application
2.5.1 Global Diabetes Injection Pens Consumption Market Share by Application (2013-2018)
2.5.2 Global Diabetes Injection Pens Value and Market Share by Application (2013-2018)
2.5.3 Global Diabetes Injection Pens Sale Price by Application (2013-2018)
3 Global Diabetes Injection Pens by Players
3.1 Global Diabetes Injection Pens Sales Market Share by Players
3.1.1 Global Diabetes Injection Pens Sales by Players (2016-2018)
3.1.2 Global Diabetes Injection Pens Sales Market Share by Players (2016-2018)
3.2 Global Diabetes Injection Pens Revenue Market Share by Players
3.2.1 Global Diabetes Injection Pens Revenue by Players (2016-2018)
3.2.2 Global Diabetes Injection Pens Revenue Market Share by Players (2016-2018)
3.3 Global Diabetes Injection Pens Sale Price by Players
3.4 Global Diabetes Injection Pens Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Diabetes Injection Pens Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Diabetes Injection Pens Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Diabetes Injection Pens by Regions
4.1 Diabetes Injection Pens by Regions
4.1.1 Global Diabetes Injection Pens Consumption by Regions
4.1.2 Global Diabetes Injection Pens Value by Regions
4.2 Americas Diabetes Injection Pens Consumption Growth
4.3 APAC Diabetes Injection Pens Consumption Growth
4.4 Europe Diabetes Injection Pens Consumption Growth
4.5 Middle East & Africa Diabetes Injection Pens Consumption Growth
5 Americas
5.1 Americas Diabetes Injection Pens Consumption by Countries
5.1.1 Americas Diabetes Injection Pens Consumption by Countries (2013-2018)
5.1.2 Americas Diabetes Injection Pens Value by Countries (2013-2018)
5.2 Americas Diabetes Injection Pens Consumption by Type
5.3 Americas Diabetes Injection Pens Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Diabetes Injection Pens Consumption by Countries
6.1.1 APAC Diabetes Injection Pens Consumption by Countries (2013-2018)
6.1.2 APAC Diabetes Injection Pens Value by Countries (2013-2018)
6.2 APAC Diabetes Injection Pens Consumption by Type
6.3 APAC Diabetes Injection Pens Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Diabetes Injection Pens by Countries
7.1.1 Europe Diabetes Injection Pens Consumption by Countries (2013-2018)
7.1.2 Europe Diabetes Injection Pens Value by Countries (2013-2018)
7.2 Europe Diabetes Injection Pens Consumption by Type
7.3 Europe Diabetes Injection Pens Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Diabetes Injection Pens by Countries
8.1.1 Middle East & Africa Diabetes Injection Pens Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Diabetes Injection Pens Value by Countries (2013-2018)
8.2 Middle East & Africa Diabetes Injection Pens Consumption by Type
8.3 Middle East & Africa Diabetes Injection Pens Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Diabetes Injection Pens Distributors
10.3 Diabetes Injection Pens Customer
11 Global Diabetes Injection Pens Market Forecast
11.1 Global Diabetes Injection Pens Consumption Forecast (2018-2023)
11.2 Global Diabetes Injection Pens Forecast by Regions
11.2.1 Global Diabetes Injection Pens Forecast by Regions (2018-2023)
11.2.2 Global Diabetes Injection Pens Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Diabetes Injection Pens Forecast by Type
11.8 Global Diabetes Injection Pens Forecast by Application
12 Key Players Analysis
12.1 Novo Nordisk
12.1.1 Company Details
12.1.2 Diabetes Injection Pens Product Offered
12.1.3 Novo Nordisk Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Novo Nordisk News
12.2 Eli Lilly
12.2.1 Company Details
12.2.2 Diabetes Injection Pens Product Offered
12.2.3 Eli Lilly Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Eli Lilly News
12.3 AstraZeneca
12.3.1 Company Details
12.3.2 Diabetes Injection Pens Product Offered
12.3.3 AstraZeneca Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 AstraZeneca News
12.4 Sanofi
12.4.1 Company Details
12.4.2 Diabetes Injection Pens Product Offered
12.4.3 Sanofi Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Sanofi News
12.5 Becton Dickinson
12.5.1 Company Details
12.5.2 Diabetes Injection Pens Product Offered
12.5.3 Becton Dickinson Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Becton Dickinson News
12.6 Owen Mumford
12.6.1 Company Details
12.6.2 Diabetes Injection Pens Product Offered
12.6.3 Owen Mumford Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Owen Mumford News
12.7 Delfu
12.7.1 Company Details
12.7.2 Diabetes Injection Pens Product Offered
12.7.3 Delfu Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Delfu News
12.8 Wockhardt Diabetes
12.8.1 Company Details
12.8.2 Diabetes Injection Pens Product Offered
12.8.3 Wockhardt Diabetes Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Wockhardt Diabetes News
13 Research Findings and Conclusion
